Literature DB >> 9548599

An efficient chromatographic system for lipoprotein fractionation using whole plasma.

W Innis-Whitehouse1, X Li, W V Brown, N A Le.   

Abstract

We have validated a semi-automatic procedure for the efficient isolation of plasma lipoproteins from 300 microl of whole plasma (actual injection volume 200 microl) by Fast Phase Liquid Chromatography (FPLC). Modified enzymatic assays were established to allow the determination of low concentrations (1-20 mg/dl) of triglycerides and cholesterol using the Beckman CX-5 Autoanalyzer. The sum of the cholesterol contents in the fractions corresponding to low density (LDL) and high density lipoprotein (HDL) can be demonstrated to be highly correlated to values obtained with dextran sulfate/MgCl2 precipitation for HDLc (slope = 0.98, r2 = 0.997) and ultracentrifugation (beta-quant) for LDLc (slope = 1.03, r2 = 0.988). Using pure lipoprotein fractions isolated by ultracentrifugation, linear ranges of detection for HDLc and HDL apoA-I were performed at 18-95 mg/dl and 59-262 mg/dl, respectively. The ranges for LDLc were 41-435 mg/dl and 21-280 mg/dl for LDL apoB. The mean (range) fractional standard deviations for quadruplicate runs for 15 individual plasma samples ranging widely in lipoprotein concentrations were 0.97 (0.29-2.86%) for LDLc (range: 101.5-258.5 mg/dl), 3.67 (0.62-14.11%) for HDLc (range: 27.1-85.1 mg/dl) and 2.19 (0.16-6.56%) for VLDL-TG (range: 6.1-515.0 mg/dl).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9548599

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  17 in total

Review 1.  Small, dense low-density lipoprotein: risk or myth?

Authors:  Ngoc-Anh Le
Journal:  Curr Atheroscler Rep       Date:  2003-01       Impact factor: 5.113

2.  Disruption of endothelial peroxisome proliferator-activated receptor γ accelerates diet-induced atherogenesis in LDL receptor-null mice.

Authors:  Aijuan Qu; Yatrik M Shah; Soumen K Manna; Frank J Gonzalez
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-10-20       Impact factor: 8.311

3.  Integrated approach for the comprehensive characterization of lipoproteins from human plasma using FPLC and nano-HPLC-tandem mass spectrometry.

Authors:  Lisamarie A Collins; Shama P Mirza; Ahmed H Kissebah; Michael Olivier
Journal:  Physiol Genomics       Date:  2009-11-10       Impact factor: 3.107

4.  Multidimensional profiling of plasma lipoproteins by size exclusion chromatography followed by reverse-phase protein arrays.

Authors:  Gregor Dernick; Stefan Obermüller; Cyrill Mangold; Christine Magg; Hugues Matile; Oliver Gutmann; Elisabeth von der Mark; Corinne Handschin; Cyrille Maugeais; Eric J Niesor
Journal:  J Lipid Res       Date:  2011-10-04       Impact factor: 5.922

5.  Lipoprotein (a) upregulates ABCA1 in liver cells via scavenger receptor-B1 through its oxidized phospholipids.

Authors:  Monika Sharma; Anne Von Zychlinski-Kleffmann; Carolyn M Porteous; Gregory T Jones; Michael J A Williams; Sally P A McCormick
Journal:  J Lipid Res       Date:  2015-04-06       Impact factor: 5.922

6.  Dietary fructose reduction improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD.

Authors:  Ran Jin; Jean A Welsh; Ngoc-Anh Le; Jeffrey Holzberg; Puneet Sharma; Diego R Martin; Miriam B Vos
Journal:  Nutrients       Date:  2014-08-08       Impact factor: 5.717

7.  The relationship of apolipoprotein B and very low density lipoprotein triglyceride with hyperuricemia and gout.

Authors:  Humaira Rasheed; Angela Hsu; Nicola Dalbeth; Lisa K Stamp; Sally McCormick; Tony R Merriman
Journal:  Arthritis Res Ther       Date:  2014-11-29       Impact factor: 5.156

8.  Effect of omega-3 fatty acid ethyl esters on the oxylipin composition of lipoproteins in hypertriglyceridemic, statin-treated subjects.

Authors:  John W Newman; Theresa L Pedersen; Verdayne R Brandenburg; William S Harris; Gregory C Shearer
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

9.  β-COP as a Component of Transport Vesicles for HDL Apolipoprotein-Mediated Cholesterol Exocytosis.

Authors:  Weilie Ma; Margarita Lin; Hang Ding; Guorong Lin; Zhizhen Zhang
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

10.  Genetic disruption of myostatin reduces the development of proatherogenic dyslipidemia and atherogenic lesions in Ldlr null mice.

Authors:  Powen Tu; Shalender Bhasin; Paul W Hruz; Karen L Herbst; Lawrence W Castellani; Ning Hua; James A Hamilton; Wen Guo
Journal:  Diabetes       Date:  2009-06-09       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.